GLP-1 Agonists and HIV: Do Weight-Loss Drugs Make Sense for Your Patients?     Three GLP-1 agonist drugs (which originally had been confined to diabetes treatment) are currently FDA approved specifically for weight loss. The rapid uptake of these medications in the U.S. has naturally led to questions within the HIV clinical community about their safety and efficacy in people living with HIV, whose journeys with weight gain and weight loss overlap with the general population but also may...

For all too many people living with HIV in the U.S., the prospect of facing incarceration because of their status is not an abstraction: It is a real and present danger. And in many states, it has nothing to do with science. This month, Juan Michael Porter II speaks with Joseph Cherabie, M.D., M.Sc., about why it's so important for clinicians to educate themselves about HIV criminalization laws in their state -- and then work to support and empower their patients while pushing to get these...

Summer weather is transitioning into sweater weather in most of the U.S., and that means we -- and our patients -- are about to spend a lot more time indoors, inevitably getting exposed to numerous microbes. Accordingly, this month we're talking about vaccinations for people living with HIV: why they're critical, what to consider, how to discuss the topic with your patients, and how to help ensure people living with HIV equitably receive the care they deserve.     Our guests for this...

This month, we’re clearing the air around integrase inhibitors. They are by far the world’s most commonly prescribed HIV drug class -- but that ubiquity has come with long-standing concerns around their potential to cause a range of adverse events, from weight gain to birth defects and more. Our executive editor Myles Helfand speaks with Laura Waters, M.D., FRCP, the head of the British HIV Association, about what the available science tells us.     Read the transcript: ...

This month, Juan Michael Porter II speaks with Tristan Barber, M.D., FRCP, about the challenges we face in determining the precise causes of particular health complications in people living with HIV. As importantly, they discuss how a provider can best make sense of these challenges and work through them to continue to provide exceptional, supportive patient care.     Read the transcript: https://www.thebodypro.com/article/future-hiv-care-podcast-treatment-tristan-barber     Credits:...

The concept of "patient-centered care" can feel both nebulous and obvious: As a clinician treating a patient, are you not by definition providing patient-centered care? There is a key difference, however, between care that focuses on the patient and care that centers each patient as a unique individual in need of a specifically tailored approach.     This month, podcast co-hosts Myles Helfand and Juan Michael Porter II dig into this issue, and discuss how conversations about achieving...

Your Patients Are Probably Having Anal Sex. Let's Talk About It.       It’s Pride Month, so we thought: Why don’t we talk about anal health? (Or, as we will frequently refer to it on this podcast, butt stuff?)     We know it’s a taboo, and many of us are uncomfortable discussing it with our patients. But even though it is awkward, when we recognize that HIV transmissions often occur through anal sex -- and that regardless of sex or gender, many people have anal sex at some point,...

In the United States, some of our most innovative steps forward in HIV care and research are taking place at one of the oldest HIV care facilities in the world. Humbly named Ward 86, this unassuming wing of San Francisco General Hospital opened 40 years ago as the first U.S. clinic dedicated specifically to the treatment of people living with HIV. Since then, it has been at the forefront of a host of initiatives and programs that seek to improve access to HIV prevention and treatment—and to...

This month, we speak with Kathie M. Hiers and Jean Hernandez of AIDS Alabama about how to overcome barriers to care for vulnerable people -- and how administrators and clinicians alike can better ensure that everyone accesses the services they need.     Read the transcript: https://www.thebodypro.com/article/future-hiv-care-podcast-15-aids-alabama     This month’s episode is hosted by Juan Michael Porter II. Our executive producer is Myles Helfand; our project manager is Alina...

This month, we’re going to explore a significant set of recent changes to U.S. HIV clinical guidelines. These changes are momentous in and of themselves, but they also reveal an important ongoing shift in how we fundamentally approach the clinician-patient relationship, especially when it comes to pregnant and infant-feeding people who are living with HIV.     Joining us for this conversation are two people who have been deeply involved in these guideline changes: Lealah Pollock, M.D., and...

It’s Black History Month, the shortest month of the year. It's not enough to simply talk about racism in health care as an issue or to acknowledge that the house is on fire; at a certain point, one has to formulate a game plan for addressing the issue effectively beyond analyzing data and conducting studies.     We speak with Susan Cole-Haley, an incredible HIV advocate and Black woman who is living with HIV, about her experience and creating a way forward. We also speak with John...

This month, we take stock of the most notable developments in 2022 that affected HIV medicine and clinical practice in the U.S. — and we'll also take a glimpse at the highlights that 2023 may hold in store. Our guide on this journey is David Alain Wohl, M.D., a professor of medicine in the Division of Infectious Diseases at the University of North Carolina. He's the author of an annual opus on TheBodyPro in which he delves deeply into the top 10 HIV-related clinical developments of the year. ...

Over the long term, successful HIV treatment is not about addressing a single issue; it requires a full continuum of care. Anita Ravi, M.D., M.P.H., the founder and medical director of the PurpLE Clinic, shares how clinicians can best address the small-but-critical moments in the patient-provider relationship that make the difference between optimal outcomes and people falling out of care.     Read the transcript: ...

Drug use is highly stigmatized not only within U.S. society, but within our health care system as well. This is all the more concerning in the context of HIV care, given the stigmas already associated with HIV. But it's within our power as health care providers to change that. In this month's episode, Joshua Barocas, M.D., of University of Colorado School of Medicine, explains how -- and why it's both cost-effective and morally imperative to do so.     Read the full transcript: ...

For providers of HIV-related care and services in the U.S., the legal landscape has grown more fraught in recent years. Despite protections baked into the Affordable Care Act, acts of medical discrimination are on the rise -- and are sometimes even encouraged by a provider's institution. We speak with Valerie Blake, J.D., of West Virginia University about these current realities, and how providers can work within the law to administer just, equitable, and science-based care to their...

This month, we talk with Joseph Cherabie, M.D., M.Sc., of the Washington University School of Medicine about the keys to successfully taking a sexual history and discussing sex with your patients.   Though sexuality is an essential aspect of our humanity, taking a sexual history can often be a challenging experience for providers and a traumatizing one for patients. But to provide effective HIV care, speaking to patients about their sexual health is crucial. We discuss how to communicate...

We talk with Gregorio (Greg) Millett, M.P.H., a longtime HIV and public health advocate, about the implicit (and explicit) stigmas that harm our ability to fully tackle the new monkeypox epidemic—and about how we can do better as a clinical community. We'll also dispel a few medical misconceptions about monkeypox along the way.     Read the full transcript, which includes links to the many studies cited throughout this conversation: ...

This month, gastroenterologist Jessica Korman, M.D., joins us to discuss one of the more common, yet underscreened, comorbidities that an HIV care provider can encounter in their patient: anal cancer and its precursors. Korman is a co-author of the newly published ANCHOR study, which explores the value of treating (versus simply observing) high-risk, pre-cancerous anal lesions. In this episode, she shares highlights of the ANCHOR study results, analyzes their clinical implications, and talks...

Please note that this episode discusses depression and suicide, which some listeners may find triggering. IF YOU NEED HELP: The peer counseling service we discuss within this episode is called the Physician Support Line; it can be reached at 888-409-0141. It is a free service available every day between 8 a.m. and 1 a.m. Eastern Time.     For this podcast, we are stepping away from the discussion around what doctors and medical professionals need to do in order to be better. This framing...

For this episode, we are looking at the provision of trauma-informed care to people who have experienced sexual assault. This includes, but is not limited to, helping survivors regain a feeling of control, effectively communicating with patients, and offering STI testing. Amanda Reames Pitelli, ANRP, M.S.N., the director of clinical services at Planned Parenthood of Metropolitan Washington, D.C., joins us to talk about simple, specific steps HIV clinicians can take to create a safe space for...

There have been quite a few moments from our prior interviews that felt powerful and important, but which didn’t make the cut for the final podcast audio, usually due to time constraints. These are moments that embrace the essence of this podcast, which is to go beyond the data to discuss where HIV medicine and services are changing in the United States, and to talk about how we can learn and adapt to create better outcomes for patients and clients and, ultimately, to lead to a better future....

We talk with Chloe Orkin, M.D., about one aspect of our future that in some very concrete ways has already arrived, and yet is currently out of reach for millions: long-acting medical interventions for HIV, the first of which were approved in the U.S. and Europe for treatment over a year ago and approved in the U.S. for prevention late last year. The beginning of the long-acting era has revealed anew some longstanding questions regarding who these drugs primarily benefit, who is able to...

For our second episode, we tackle structural racism and power differentials in HIV care and services within the U.S. We focus on acknowledging current issues and identifying potential solutions that providers can employ in their daily work. Our staff writer Juan Michael Porter II takes the host chair.    We have two guests in store this month: Michael Chancley, M.S.W., and Deb Cohan, M.D., M.P.H.   Chancley is a social worker, educator, writer, and HIV advocate whose work in the South has...

We review some of the most important clinical developments in HIV that we’ve witnessed in 2021, with an eye toward how those developments will inform and alter our response to HIV in 2022 and beyond.   Our guest: David Alain Wohl, M.D., a professor of medicine in the Division of Infectious Diseases at the University of North Carolina and the site leader of the HIV Prevention and Treatment Clinical Trials Unit at UNC Chapel Hill.   Our topics: HIV and COVID-19; long-acting antiretroviral...